These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15895304)

  • 1. Relapse of primary CNS lymphoma after more than 10 years in complete remission.
    Herrlinger U; Hebart H; Kanz L; Dichgans J; Weller M
    J Neurol; 2005 Nov; 252(11):1409-10. PubMed ID: 15895304
    [No Abstract]   [Full Text] [Related]  

  • 2. Late relapse of primary central nervous system lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Sano M; Homma J; Tsuchiya N; Yajima N; Tsukamoto Y; Ogura R; Natsumeda M; Aoki H; Akiyama K; Saitoh T; Tamura T; Hondoh H; Kawaguchi A; Takahashi H; Fujii Y
    Leuk Lymphoma; 2017 Feb; 58(2):475-477. PubMed ID: 27397141
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
    Soussain C; Suzan F; Hoang-Xuan K; Cassoux N; Levy V; Azar N; Belanger C; Achour E; Ribrag V; Gerber S; Delattre JY; Leblond V
    J Clin Oncol; 2001 Feb; 19(3):742-9. PubMed ID: 11157026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal lymphoma: a reappraisal.
    Zucca E
    Ann Oncol; 2008 Jun; 19 Suppl 4():iv77-80. PubMed ID: 18519412
    [No Abstract]   [Full Text] [Related]  

  • 6. PCV salvage chemotherapy for recurrent primary CNS lymphoma.
    Herrlinger U; Brugger W; Bamberg M; Küker W; Dichgans J; Weller M
    Neurology; 2000 Apr; 54(8):1707-8. PubMed ID: 10762527
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment for primary CNS lymphoma: the next step.
    Abrey LE; Yahalom J; DeAngelis LM
    J Clin Oncol; 2000 Sep; 18(17):3144-50. PubMed ID: 10963643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO; Fischer DH
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system lymphoma with testicular metastasis.
    Liu XJ; Zhao JZ; Li G; Ye X; Yan PX
    Clin Neurol Neurosurg; 2012 Jan; 114(1):80-3. PubMed ID: 21871714
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of non-Hodgkin lymphoma in the central nervous system, developing during treatment of galactorrhea amenorrhea syndrome].
    Matsuda M; Hattori T; Tabata K; Seki S
    Rinsho Shinkeigaku; 1999 Nov; 39(11):1160-3. PubMed ID: 10689943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
    Enting RH; Demopoulos A; DeAngelis LM; Abrey LE
    Neurology; 2004 Sep; 63(5):901-3. PubMed ID: 15365145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
    Nguyen DT; Houillier C; Choquet S; Cassoux N; Soussain C; Le Cossec C; Legarf-Tavernier M; Costopoulos M; LeHoang P; Bodaghi B; Omuro A; Hoang-Xuan K; Touitou V
    Ophthalmology; 2016 Sep; 123(9):2047-50. PubMed ID: 27137876
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man.
    Partap S; Spence AM
    J Neurooncol; 2006 Dec; 80(3):305-7. PubMed ID: 16794747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of FISH in an aggressive diffuse large B cell lymphoma.
    Smith A; Kirkpatrick P; St Heaps L; Sharma P; Roman M; Harvey T; Crombie C
    Pathology; 2003 Feb; 35(1):90-2. PubMed ID: 12701697
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study.
    Gururangan S; Sposto R; Cairo MS; Meadows AT; Finlay JL
    J Clin Oncol; 2000 May; 18(10):2017-25. PubMed ID: 10811665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary CNS lymphoma.
    Schmitz N
    Blood; 2015 Feb; 125(9):1360-1. PubMed ID: 25721041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.